Regulation of activity of the transcription factor GATA-1 by acetylation
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Modification of histones, DNA-binding proteins found in chromatin, by addition of acetyl groups occurs to a greater degree when the histones are associated with transcriptionally active DNA. A breakthrough in understanding how this acetylation is mediated was the discovery that various transcriptional co-activator proteins have intrinsic histone acetyltransferase activity (for example, Gcn5p, PCAF, TAF(II)250 and p300/CBP. These acetyltransferases also modify certain transcription factors (TFIIEbeta, TFIIF, EKLF and p53). GATA-1 is an important transcription factor in the haematopoietic lineage and is essential for terminal differentiation of erythrocytes and megakaryocytes. It is associated in vivo with the acetyltransferase p300/CBP. Here we report that GATA-1 is acetylated in vitro by p300. This significantly increases the amount of GATA-1 bound to DNA and alters the mobility of GATA-1-DNA complexes, suggestive of a conformational change in GATA-1. GATA-1 is also acetylated in vivo and acetylation directly stimulates GATA-1-dependent transcription. Mutagenesis of important acetylated residues shows that there is a relationship between the acetylation and in vivo function of GATA-1. We propose that acetylation of transcription factors can alter interactions between these factors and DNA and among different transcription factors, and is an integral part of transcription and differentiation processes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CBP acetylates GATA-1 at two highly conserved lysine-rich motifs near each of the two zinc fingers (10, 27).”
From Inhibition of CBP-Mediated Protein Acetylation by the Ets Family Oncoprotein PU.1 (2002) · cites this paper as [10]
In the citing paper
“The basic tail of the GATA-1 CF has been shown to undergo a number of post-translational modifications.”
From Molecular Analysis of the Interaction between the Hematopoietic Master Transcription Factors GATA-1 and PU.1 (2006) · cites this paper as [34]
Citations
Cites
The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., & Nakatani, Y. (1996) · Cell · doi:10.1016/s0092-8674(00)82001-2 · Cited by 2,952
Self-citationHistone acetylation in chromatin structure and transcription
Grunstein, M. (1997) · Nature · doi:10.1038/38664 · Cited by 2,884 · cited 1×
“gif" NDATA ITEM> ]> Modification of histones, DNA-binding proteins found in chromatin, by addition of acetyl groups occurs to a greater degree when the histones are associated with transcriptionally active DN”
BackgroundActivation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559 · cited 1×
“These acetyltransferases also modify certain transcription factors (TFIIEβ, TFIIF, EKLF and p53”
BackgroundThe CBP co-activator is a histone acetyltransferase
Bannister, A. J., & Kouzarides, T. (1996) · Nature · doi:10.1038/384641a0 · Cited by 1,805
Brownell, J. E., Zhou, J., Ranalli, T., Kobayashi, R., Edmondson, D. G., Roth, S. Y., & Allis, C. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81063-6 · Cited by 1,640 · cited 1×
“A breakthrough in understanding how this acetylation is mediated was the discovery that various transcriptional co-activator proteins have intrinsic histone acetyltransferase activity (for example, Gcn5p”
BackgroundA p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
Yang, X.-J., Ogryzko, V. V., Nishikawa, J.-I., Howard, B. H., & Nakatani, Y. (1996) · Nature · doi:10.1038/382319a0 · Cited by 1,479
Self-citationPevny, L., Simon, M. C., Robertson, E., Klein, W. H., Tsai, S.-F., D'Agati, V., Orkin, S. H., & Costantini, F. (1991) · Nature · doi:10.1038/349257a0 · Cited by 1,308 · cited 1×
“and is essential for terminal differentiation of erythrocytes and megakaryocyte”
BackgroundA direct link between core histone acetylation and transcriptionally active chromatin.
Hebbes, T. R., Thorne, A. W., & Crane-Robinson, C. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02956.x · Cited by 923
GATA-binding transcription factors in hematopoietic cells
Orkin, S. (1992) · Blood · doi:10.1182/blood.v80.3.575.575 · Cited by 884 · cited 1×
“GATA-1 is an important transcription factor in the haematopoietic lineag”
BackgroundThe TAFII250 Subunit of TFIID Has Histone Acetyltransferase Activity
Mizzen, C. A., Yang, X.-J., Kokubo, T., Brownell, J. E., Bannister, A. J., Owen-Hughes, T., Workman, J., Wang, L., Berger, S. L., Kouzarides, T., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81821-8 · Cited by 727
Self-citation
Cited by
Roth, S. Y., Denu, J. M., & Allis, C. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.81 · Cited by 1,845
Acetylation of Histones and Transcription-Related Factors
Sterner, D. E., & Berger, S. L. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.2.435-459.2000 · Cited by 1,780
“p300 and CBP have recently been shown to acetylate GATA-1 in vitro at two lysine-rich motifs within this central region (24, 110).”
BackgroundCBP/p300 in cell growth, transformation, and development
Goodman, R. H., & Smolik, S. (2000) · Genes & Development · doi:10.1101/gad.14.13.1553 · Cited by 1,778
“In one study, acetylation of GATA-1 was shown to increase DNA-binding (Boyes et al. 1998).”
BackgroundInfluentialAcetylation and deacetylation of non-histone proteins
Glozak, M. A., Sengupta, N., Zhang, X., & Seto, E. (2005) · Gene · doi:10.1016/j.gene.2005.09.010 · Cited by 1,584
Shaping the nuclear action of NF-κB
Chen, L.-F., & Greene, W. C. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1368 · Cited by 1,221
“and alters the affinity of p53 and the GATA1 transcription factor for their DNA-binding site”
BackgroundFunctions and mechanisms of non-histone protein acetylation
Narita, T., Weinert, B. T., & Choudhary, C. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0081-3 · Cited by 1,232
Acetylation: a regulatory modification to rival phosphorylation?
Kouzarides, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.6.1176 · Cited by 1,160
“Many of these substrates are involved in the regulation of transcription and include p53, E2F1, EKLF, TFIIEβ, TFIIF, TCF, GATA1, HMGI(Y) and ACTR (Gu and Roeder, 1997; Imhof et al., 1997; Boyes et al., 1998; Munshi et al., 1998; Waltzer and Bienz, 1998; Zhang and Bieker et al., 1998; Chen et al., 1999; Martı́nez-Balbá…”
BackgroundInfluentialHistone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cells
Marks, P. A., Richon, V. M., & Rifkind, R. A. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1210 · Cited by 1,157
p300/CBP proteins: HATs for transcriptional bridges and scaffolds
Chan, H. M., & La Thangue, N. B. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.13.2363 · Cited by 1,092
Histone deacetylases and cancer
Glozak, M. A., & Seto, E. (2007) · Oncogene · doi:10.1038/sj.onc.1210610 · Cited by 1,031
Modulation of cellular processes by histone and non-histone protein acetylation
Shvedunova, M., & Akhtar, A. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00441-y · Cited by 936
TRANSCRIPTION OF EUKARYOTIC PROTEIN-CODING GENES
Lee, T. I., & Young, R. A. (2000) · Annual Review of Genetics · doi:10.1146/annurev.genet.34.1.77 · Cited by 860
Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF‐κB
Chen, L., Mu, Y., & Greene, W. C. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf660 · Cited by 827
CBP Histone Acetyltransferase Activity Is a Critical Component of Memory Consolidation
Korzus, E., Rosenfeld, M. G., & Mayford, M. (2004) · Neuron · doi:10.1016/j.neuron.2004.06.002 · Cited by 823
Ito, K., Barnes, P. J., & Adcock, I. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.18.6891-6903.2000 · Cited by 723
“Direct acetylation has been shown to be important in the activity of some transcription factors and coactivators (5, 12, 14).”
BackgroundRegulation and Destabilization of HIF-1α by ARD1-Mediated Acetylation
Jeong, J.-W., Bae, M.-K., Ahn, M.-Y., Kim, S.-H., Sohn, T.-K., Bae, M.-H., Yoo, M.-A., Song, E. J., Lee, K.-J., & Kim, K.-W. (2002) · Cell · doi:10.1016/s0092-8674(02)01085-1 · Cited by 716
Wang, Q., Li, W., Liu, X. S., Carroll, J. S., Jänne, O. A., Keeton, E. K., Chinnaiyan, A. M., Pienta, K. J., & Brown, M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.041 · Cited by 687
“Previous studies have found that other GATA family members can open the compact chromatin through their conserved zinc finger motifs (Boyes et al., 1998; Cirillo et al., 2002).”
BackgroundRegulation of E2F1 activity by acetylation
Martínez-Balbás, M. A., Bauer, U.-M., Nielsen, S. J., Brehm, A., & Kouzarides, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.4.662 · Cited by 671
“TFIIF, EKLF, p53, HMGI(Y) and GATA-1 (Gu andE2F activity is regulated principally by association with Roeder, 1997; Imhof et al., 1997; Boyes et al., 1998;different regulators.”
BackgroundAcetylation of non-histone proteins modulates cellular signalling at multiple levels
Spange, S., Wagner, T., Heinzel, T., & Krämer, O. H. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.08.027 · Cited by 664
Iyer, N. G., Özdag, H., & Caldas, C. (2004) · Oncogene · doi:10.1038/sj.onc.1207118 · Cited by 638
“…(2004) 23, 4225–4231 & 2004 Nature Publishing Group All rights reserved 0950-9232/04 $30.00 www.nature.com/onc (Gu and Roeder, 1997; Boyes et al., 1998; Munshi et al., 1998; Sakaguchi et al., 1998; Bannister et al., 2000; Martinez-Balbas et al., 2000; Marzio et al., 2000; Tomita…”
BackgroundInfluentialHistone deacetylases, transcriptional control, and cancer
Cress, W. D., & Seto, E. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200007)184:1<1::aid-jcp1>3.0.co;2-7 · Cited by 621
Transcriptional regulation of erythropoiesis: an affair involving multiple partners
Cantor, A. B., & Orkin, S. H. (2002) · Oncogene · doi:10.1038/sj.onc.1205326 · Cited by 594
“This may be an oversimpli®cation, as GATA-1 protein itself is acetylated on conserved lysine residues by CBP, a modi®cation which appears to enhance its transcriptional activity (Hung et al., 1999; Boyes et al., 1998).”
BackgroundThe SMRT and N-CoR Corepressors Are Activating Cofactors for Histone Deacetylase 3
Guenther, M. G., Barak, O., & Lazar, M. A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.18.6091-6101.2001 · Cited by 611
“Gal4SMRT DAD mutants W432A, F440A, F451A, I454A, L458A, V463A, and Y470A were produced using the corresponding mutagenic oligonucleotides and the QuickChange site-directed mutagenesis kit (Stratagene).”
BackgroundInfluentialp300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2
Ito, A., Lai, C.-H., Zhao, X., Saito, S., Hamilton, M. H., Appella, E., & Yao, T.-P. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1331 · Cited by 582
The transcriptional role of PML and the nuclear body
Zhong, S., Salomoni, P., & Pandolfi, P. P. (2000) · Nature Cell Biology · doi:10.1038/35010583 · Cited by 577
“, which acetylates and activates p53 and the transcription factors GATA-1 (ref”
BackgroundInan, M. S., Rasoulpour, R. J., Yin, L., Hubbard, A. K., Rosenberg, D. W., & Giardina, C. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70142-9 · Cited by 499
Estrogen receptor interaction with co-activators and co-repressors☆
Klinge, C. M. (2000) · Steroids · doi:10.1016/s0039-128x(99)00107-5 · Cited by 491
CLINICAL DEVELOPMENT OF HISTONE DEACETYLASE INHIBITORS AS ANTICANCER AGENTS
Drummond, D. C., Noble, C. O., Kirpotin, D. B., Guo, Z., Scott, G. K., & Benz, C. C. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095825 · Cited by 494
Ca2+/CaM-Dependent Kinases: From Activation to Function
Hook, S. S., & Means, A. R. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.471 · Cited by 482
Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key?
Thomas, M. J., & Seto, E. (1999) · Gene · doi:10.1016/s0378-1119(99)00261-9 · Cited by 465
GATA1 Function, a Paradigm for Transcription Factors in Hematopoiesis
Ferreira, R., Ohneda, K., Yamamoto, M., & Philipsen, S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.4.1215-1227.2005 · Cited by 442
“reported that in chicken GATA1, acetylation increased DNA-binding activity (6), but Hung et al.”
BackgroundInfluentialRegulation of Transcription Factor YY1 by Acetylation and Deacetylation
Yao, Y.-L., Yang, W.-M., & Seto, E. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5979-5991.2001 · Cited by 434
“Acetylation has been shown to regulate the activity of many transcription factors, including sequence-specific DNA-binding factors p53 (18), GATA-1 (5, 27), E2F (43, 44), and MyoD (53).”
BackgroundMetabolic engineering strategies for the improvement of cellulase production by Hypocrea jecorina
Kubicek, C. P., Mikus, M., Schuster, A., Schmoll, M., & Seiboth, B. (2009) · Biotechnology for Biofuels · doi:10.1186/1754-6834-2-19 · Cited by 423
“Thereby the action of acetyltransferases may play a role in the local disruption of nucleosomes since an association of GATA-1 and NF-Y with acetyltransferases p300/CBP has been shown [40,41].”
BackgroundNovel histone deacetylase inhibitors in clinical trials as anti-cancer agents
Tan, J., Cang, S., Ma, Y., Petrillo, R. L., & Liu, D. (2010) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-3-5 · Cited by 425
“Acetylation and deacetylation of sequence-specific transcription factors can either increase or decrease their DNA binding activity, and subsequently may enhance or repress transcription [64-68].”
Transcriptional Activation by NF-κB Requires Multiple Coactivators
Sheppard, K.-A., Rose, D. W., Haque, Z. K., Kurokawa, R., McInerney, E., Westin, S., Thanos, D., Rosenfeld, M. G., Glass, C. K., & Collins, T. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6367 · Cited by 434
“Similarly, GATA-1 is acetylated in vitro by the HAT activity of p300 (4).”
BackgroundHistone Deacetylases Specifically Down-regulate p53-dependent Gene Activation
Juan, L.-J., Shia, W.-J., Chen, M.-H., Yang, W.-M., Seto, E., Lin, Y.-S., & Wu, C.-W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000202200 · Cited by 419
HIV-1 Tat transcriptional activity is regulated by acetylation
Kiernan, R. E. (1999) · The EMBO Journal · doi:10.1093/emboj/18.21.6106 · Cited by 416
“This is consistent with suggested conformational changes in p53 (Gu and Roeder, 1997) and GATA-1 (Boyes et al., 1998) occurring as a consequence of acetylation.”
BackgroundSelf-citationNg (2000) · doi:10.1016/s0968-0004(00)01551-6 · Cited by 427
Ryan, Q. C., Headlee, D., Acharya, M., Sparreboom, A., Trepel, J. B., Ye, J., Figg, W. D., Hwang, K., Chung, E. J., Murgo, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.188 · Cited by 411
Fu, M., Wang, C., Reutens, A. T., Wang, J., Angeletti, R. H., Siconolfi-Baez, L., Ogryzko, V., Avantaggiati, M.-L., & Pestell, R. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000660200 · Cited by 409
Self-citationAcetylation inactivates the transcriptional repressor BCL6
Bereshchenko, O. R., Gu, W., & Dalla-Favera, R. (2002) · Nature Genetics · doi:10.1038/ng1018 · Cited by 394
“Antibodies against BCL6 (N3 and C19), against GAL4 (DBD), against Notch2 (25-255) and against HDAC2 (H54) were purchased from Santa Cruz Biotechnology.”
MethodTranscriptional repression by REST: recruitment of Sin3A and histone deacetylase to neuronal genes
Huang, Y., Myers, S. J., & Dingledine, R. (1999) · Nature Neuroscience · doi:10.1038/13165 · Cited by 396
NF-κB1 (p50) Homodimers Differentially Regulate Pro- and Anti-inflammatory Cytokines in Macrophages
Cao, S., Zhang, X., Edwards, J. P., & Mosser, D. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602222200 · Cited by 370
Control of Smad7 Stability by Competition between Acetylation and Ubiquitination
Grönroos, E., Hellman, U., Heldin, C.-H., & Ericsson, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00639-1 · Cited by 383
Nuclear Hormone Receptor Coregulators In Action: Diversity For Shared Tasks
Robyr, D. (2000) · Molecular Endocrinology · doi:10.1210/me.14.3.329 · Cited by 381
Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics
Ali, I., Conrad, R. J., Verdin, E., & Ott, M. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00181 · Cited by 366
Wang, C., Fu, M., Angeletti, R. H., Siconolfi-Baez, L., Reutens, A. T., Albanese, C., Lisanti, M. P., Katzenellenbogen, B. S., Kato, S., Hopp, T., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100800200 · Cited by 366
Lysine acetylation and the bromodomain: a new partnership for signaling
Yang, X. (2004) · BioEssays · doi:10.1002/bies.20104 · Cited by 357
The c-MYC Oncoprotein Is a Substrate of the Acetyltransferases hGCN5/PCAF and TIP60
Patel, J. H., Du, Y., Ard, P. G., Phillips, C., Carella, B., Chen, C.-J., Rakowski, C., Chatterjee, C., Lieberman, P. M., Lane, W. S., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10826-10834.2004 · Cited by 354
“A number of well-characterized transcription factors are acetylated by mGCN5/PCAF, often with profound functional consequences (8, 13, 24, 26, 45, 47).”
BackgroundHamamori, Y., Sartorelli, V., Ogryzko, V., Puri, P. L., Wu, H.-Y., Wang, J. Y. J., Nakatani, Y., & Kedes, L. (1999) · Cell · doi:10.1016/s0092-8674(00)80553-x · Cited by 368
Self-citationPU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding
Zhang, P., Zhang, X., Iwama, A., Yu, C., Smith, K. A., Mueller, B. U., Narravula, S., Torbett, B. E., Orkin, S. H., & Tenen, D. G. (2000) · Blood · doi:10.1182/blood.v96.8.2641 · Cited by 368
Acetylation of MyoD Directed by PCAF Is Necessary for the Execution of the Muscle Program
Sartorelli, V., Puri, P. L., Hamamori, Y., Ogryzko, V., Chung, G., Nakatani, Y., Wang, J. Y. J., & Kedes, L. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80383-4 · Cited by 356
Self-citationThe Transcription Factors GATA4 and GATA6 Regulate Cardiomyocyte Hypertrophy in Vitro and in Vivo
Liang, Q., De Windt, L. J., Witt, S. A., Kimball, T. R., Markham, B. E., & Molkentin, J. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102174200 · Cited by 363
Berghe, W. V., De Bosscher, K., Boone, E., Plaisance, S., & Haegeman, G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32091 · Cited by 354
Hematopoietic cytokines, transcription factors and lineage commitment
Zhu, J., & Emerson, S. G. (2002) · Oncogene · doi:10.1038/sj.onc.1205318 · Cited by 330
“CREB-binding protein/p300 binds to GATA-1 and upregulate its DNA binding activity through acetylation (Blobel et al., 1998; Boyes et al., 1998).”
BackgroundNader, N., Chrousos, G. P., & Kino, T. (2009) · The FASEB Journal · doi:10.1096/fj.08-117697 · Cited by 340
“Third, acetylation of transcription factors, such as MyoD, p53, and GATA-1, by histone acetyltransferases also modulates the binding of these transcription factors to their specific binding elements in their responsive promoters (37, 39, 49, 50).”
BackgroundMolecular Regulation of the Endothelin-1 Gene by Hypoxia
Yamashita, K., Discher, D. J., Hu, J., Bishopric, N. H., & Webster, K. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011344200 · Cited by 340
Nuclear receptor coregulators: multiple modes of modification
Hermanson, O., Glass, C. K., & Rosenfeld, M. G. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00527-6 · Cited by 322
Huang, E. Y., Zhang, J., Miska, E. A., Guenther, M. G., Kouzarides, T., & Lazar, M. A. (2000) · Genes & Development · doi:10.1101/gad.14.1.45 · Cited by 325
“In addition to histones, protein acetylation regulates a variety of transcriptional regulators (Kouzarides 1999), including both sequence-specific transcription factors p53 (Gu and Roeder 1997; Liu et al. 1999) and GATA-1 (Boyes et al. 1998; Hung et al. 1999), the nuclear receptor coactivator ACTR (Chen et al. 1999),…”
BackgroundSarjeant, K., & Stephens, J. M. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008417 · Cited by 328
“GATA proteins can be regulated posttranslationally byacetylation, SUMOylation, and phosphorylation (Boyes et al. 1998; Chun et al. 2003; Menghini et al. 2005).”
DNA Damage-Dependent Acetylation of p73 Dictates the Selective Activation of Apoptotic Target Genes
Costanzo, A., Merlo, P., Pediconi, N., Fulco, M., Sartorelli, V., Cole, P. A., Fontemaggi, G., Fanciulli, M., Schiltz, L., Blandino, G., et al. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00431-8 · Cited by 319
Epigenetics—An Epicenter of Gene Regulation: Histones and Histone‐Modifying Enzymes
Biel, M., Wascholowski, V., & Giannis, A. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461346 · Cited by 316
Hull, E. E., Montgomery, M. R., & Leyva, K. J. (2016) · BioMed Research International · doi:10.1155/2016/8797206 · Cited by 313
“GATA family Transcription factor Increased DNA binding affinity [82, 83]”
BackgroundHu, E., Chen, Z., Fredrickson, T., Zhu, Y., Kirkpatrick, R., Zhang, G.-F., Johanson, K., Sung, C.-M., Liu, R., & Winkler, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908988199 · Cited by 309
Chen, D., Riedl, T., Washbrook, E., Pace, P. E., Coombes, R. C., Egly, J.-M., & Ali, S. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00004-3 · Cited by 290
PRC2 directly methylates GATA4 and represses its transcriptional activity
He, A., Shen, X., Ma, Q., Cao, J., von Gise, A., Zhou, P., Wang, G., Marquez, V. E., Orkin, S. H., & Pu, W. T. (2012) · Genes & Development · doi:10.1101/gad.173930.111 · Cited by 291
“Other epigenetic modifying enzymes, such as histone acetyltransferases and histone deacetylases, also modify nonhistone substrates, including transcription factors (Boyes et al. 1998; Yang and Seto 2008; Trivedi et al. 2010).”
BackgroundAcetylation and chromosomal functions
Cheung, W. L., Briggs, S. D., & Allis, C. D. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00096-x · Cited by 291
Histone deacetylase inhibitors in cancer treatment
Vigushin, D. M., & Coombes, R. C. (2002) · Anti-Cancer Drugs · doi:10.1097/00001813-200201000-00001 · Cited by 301
Regulation of FoxO transcription factors by acetylation and protein–protein interactions
Daitoku, H., Sakamaki, J.-I., & Fukamizu, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.03.001 · Cited by 283
p300 and CBP: Partners for life and death
Giordano, A., & Avantaggiati, M. L. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199911)181:2<218::aid-jcp4>3.0.co;2-5 · Cited by 291
Chen, Q., Yang, B., Liu, X., Zhang, X. D., Zhang, L., & Liu, T. (2022) · Theranostics · doi:10.7150/thno.73223 · Cited by 261
Acetylation Regulates Transcription Factor Activity at Multiple Levels
Soutoglou, E., Katrakili, N., & Talianidis, I. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80253-1 · Cited by 283
ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation
Kawasaki, H., Schiltz, L., Chiu, R., Itakura, K., Taira, K., Nakatani, Y., & Yokoyama, K. K. (2000) · Nature · doi:10.1038/35012097 · Cited by 288
Self-citationHistone deacetylase inhibitors (HDACIs): multitargeted anticancer agents
Licciardi, P., Ververis, Hiong, & Karagiannis (2013) · Biologics: Targets and Therapy · doi:10.2147/btt.s29965 · Cited by 274
Acetylation control of the retinoblastoma tumour-suppressor protein
Chan, H. M., Krstic-Demonacos, M., Smith, L., Demonacos, C., & Thangue, N. B. L. (2001) · Nature Cell Biology · doi:10.1038/35083062 · Cited by 282
Effects of glucocorticoids on gene transcription
Hayashi, R., Wada, H., Ito, K., & Adcock, I. M. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.011 · Cited by 277
Chen, L.-F., & Greene, W. C. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0469-0 · Cited by 275
“A similar mechanism has been hypothesized for GATA-1, where acetylation in the DNA binding domain enhances the DNA binding activity of this transcription factor [56].”
BackgroundNimmanapalli, R., Fuino, L., Bali, P., Gasparetto, M., Glozak, M. A., Tao, J., Moscinski, L. C., Smith, C. A., Wu, J., Jove, R., et al. (2003) · PubMed · Cited by 302
Histone deacetylases: transcriptional repression with SINers and NuRDs
Ayer, D. E. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01536-6 · Cited by 274
Butyrate Suppression of Colonocyte NF-κB Activation and Cellular Proteasome Activity
Yin, L., Laevsky, G., & Giardina, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105170200 · Cited by 266
Deng, W.-G., Tang, S.-T., Tseng, H.-P., & Wu, K. K. (2006) · Blood · doi:10.1182/blood-2005-09-3691 · Cited by 266
“Furthermore, p300 HAT has been shown to acetylate transactivators thereby enhancing their binding activity.(43) Results from recent reports have shown that deletion of p300 HAT greatly reduces the p300-mediated iNOS and COX-2 transcriptional activities.”
Role of the GATA Family of Transcription Factors in Endocrine Development, Function, and Disease
Viger, R. S., Guittot, S. M., Anttonen, M., Wilson, D. B., & Heikinheimo, M. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0513 · Cited by 270
Liang, Q., Wiese, R. J., Bueno, O. F., Dai, Y.-S., Markham, B. E., & Molkentin, J. D. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.21.7460-7469.2001 · Cited by 271
“For example, p300 was shown to directly acetylate GATA1 resulting in enhanced DNA binding activity, suggesting that other members of the GATA family might be subjected to such regulation (4).”
BackgroundMal, A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1739 · Cited by 259
Regulation of Cellulase and Hemicellulase Gene Expression in Fungi
Amore, A., Giacobbe, S., & Faraco, V. (2013) · Current Genomics · doi:10.2174/1389202911314040002 · Cited by 256
Lamonica, J. M., Deng, W., Kadauke, S., Campbell, A. E., Gamsjaeger, R., Wang, H., Cheng, Y., Billin, A. N., Hardison, R. C., Mackay, J. P., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102140108 · Cited by 238
“The hematopoietic zinc finger protein GATA1 was one of the earliest reported acetylated transcription factors (3, 4).”
BackgroundFuino, L., Bali, P., Wittmann, S., Donapaty, S., Guo, F., Yamaguchi, H., Wang, H., Atadja, P. W., & Bhalla, K. N. (2003) · PubMed · Cited by 299
CREB-binding protein and p300: molecular integrators of hematopoietic transcription
Blobel, G. A. (2000) · Blood · doi:10.1182/blood.v95.3.745.003k05_745_755 · Cited by 260
The diversity of acetylated proteins.
Polevoda, B. V., & Sherman, F. (2002) · Genome biology · doi:10.1186/gb-2002-3-5-reviews0006 · Cited by 254
“In case of the transcription factors p53, E2F1, EKLF, and GATA-1, the acetylation site is located directly adjacent to the DNA-binding domain, and acetylation stimulates DNA binding [26,30,34].”
BackgroundMolecular Cloning and Characterization of a Novel Histone Deacetylase HDAC10
Guardiola, A. R., & Yao, T.-P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109861200 · Cited by 253
Tong, Q., Tsai, J., Tan, G., Dalgin, G., & Hotamisligil, G. S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.2.706-715.2005 · Cited by 248
“For example, Rb and Trap220 were shown to be necessary for adipocyte differentiation (4, 7), and CBP heterozygous mice are lipodystrophic (24).”
Hung, H.-L., Lau, J., Kim, A. Y., Weiss, M. J., & Blobel, G. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3496 · Cited by 247
“However, in agreement with our findings, mutations in the chicken GATA-1 acetylation sites do not alter DNA binding (7).”
InfluentialTranscriptional Coregulators in Development
Mannervik, M., Nibu, Y., Zhang, H., & Levine, M. (1999) · Science · doi:10.1126/science.284.5414.606 · Cited by 241
Cardiac p300 Is Involved in Myocyte Growth with Decompensated Heart Failure
Yanazume, T., Hasegawa, K., Morimoto, T., Kawamura, T., Wada, H., Matsumori, A., Kawase, Y., Hirai, M., & Kita, T. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.10.3593-3606.2003 · Cited by 238
“The lysine residues acetylated by p300/CBP in GATA-1/3 have been mapped (8, 59).”
BackgroundOxidative stress interference with the nuclear factor- κB activation pathways
Schoonbroodt, S., & Piette, J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00371-3 · Cited by 240
E2F Family Members Are Differentially Regulated by Reversible Acetylation
Marzio, G., Wagener, C., Gutierrez, M. I., Cartwright, P., Helin, K., & Giacca, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.10887 · Cited by 231
Scazzocchio, C. (2000) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00063-1 · Cited by 232
Boudreau, F., Rings, E. H. H. M., van Wering, H. M., Kim, R. K., Swain, G. P., Krasinski, S. D., Moffett, J., Grand, R. J., Suh, E. R., & Traber, P. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204622200 · Cited by 233
Ghosh, A. K., Yuan, W., Mori, Y., & Varga, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203693 · Cited by 231
“…Livingston) contains sequences from +1134 bp to +9046 bp of p300 in CMVb (Eckner et al., 1994). p300 and p300DHAT (from J Boyes) contains Nterminal FLAG-tagged full-length p300 and N-terminal FLAG-tagged p300 lacking the HAT domain (amino acids 1472 ± 1522) in pCI respectively (Boyes et al., 1998).”
BackgroundKraus, W. L., Manning, E. T., & Kadonaga, J. T. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8123 · Cited by 233
“It is important to note, however, that the key acetylation substrate(s) that is responsible for the transcriptional effects has not yet been identified. p300/CBP has been found to acetylate components of the basal transcriptional machinery (e.g., TFIIEb and TFIIF) (30), sequence-specific transcriptional activator prot…”
Background
Metadata
- Authors
- Boyes, J., Byfield, P., Nakatani, Y., & Ogryzko, V.
- Affiliations
- Institute of Cancer Research (GB)
- Hammersmith Hospital (GB)
- National Institutes of Health (US)
- Corresponding author
- Boyes, Joan
- Venue
- Nature
- Published
- 1998-12
- Volume
- 396
- Issue
- 6711
- Pages
- 594-598
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1626483287
- Cited by
- 694
- References
- 28
- Citations by year
- 2026: 9 · 2025: 5 · 2024: 4 · 2023: 3 · 2022: 10 · 2021: 9 · 2020: 13 · 2019: 11 · 2018: 10 · 2017: 7 · 2016: 12 · 2015: 7 · 2014: 14 · 2013: 14 · 2012: 15
- FWCI
- 21.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- GATA-1, histone acetylation, CBP/p300, transcriptional coactivator, histone acetyltransferase, protein conformational change, erythroid differentiation, acetylation sites
- MeSH terms
- Acetylation, Amino Acid Sequence, Animals, Binding Sites, Chickens, DNA, DNA-Binding Proteins, Lysine, Molecular Sequence Data, Nuclear Proteins, Protein Binding, Mass Spectrometry, Transcription Factors, Transcription, Genetic, Tumor Cells, Cultured, Trans-Activators, Zinc Fingers, 3T3 Cells, E1A-Associated p300 Protein, Erythroid-Specific DNA-Binding Factors, GATA1 Transcription Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.